Insilico Studies of Turmeric(Curcuma Longa)Extract
DOI: https://doi.org/10.33003/jobasr
Sani A.K.
Hamza I.K.
Balarabe A.S.
Nasir H.N.
Kabir H. G.
Lawal R. G.
Kabir Z. G
Matazu H. K.
Bala M.G.
Abstract
Turmeric (Curcuma longa), a key ingredient in traditional medicine and cuisine, is known for its broad pharmacological properties attributed to its bioactive compounds, particularly sesquiterpenes and curcuminoids. Although its antimicrobial and anti-inflammatory activities are well-documented in ethnomedicine, the molecular basis of these effects remains underexplored, especially in relation to foodborne pathogens. Bridging the gap between traditional knowledge and modern drug discovery, Method;This study employed Gas Chromatography-Mass Spectrometry (GC-MS) technique to identify major phytocompounds in turmeric extract, followed by molecular docking analysis using Auto-dock and Auto-dock vina to evaluate their interactions with key bacterial targets—Staphylococcus aureus DNA gyrase and Klebsiella pneumoniae CTX-M-15 β-lactamase. Result;GC-MS analysis revealed dominant compounds such as alpha-cubebene (10.86%), carveol (11.59%), 2-propenal (14.29%), and caryophyllene (2.73%), many of which have reported antimicrobial and anti-inflammatory properties. Molecular docking revealed that caryophyllene exhibited moderately strong binding affinities with both microbial proteins (-6.4 and -5.6 kcal/mol), indicating potential as a natural antibacterial agent. Palmitic acid showed lower affinities but supported secondary bioactivities. These findings support the hypothesis that turmeric’s antimicrobial efficacy is driven by synergistic interactions among multiple phytochemicals at the molecular level. This study demonstrates the relevance of integrating in silico techniques into natural product research, offering a time-efficient and cost-effective method for screening bioactive compounds. Conclusion: The result highlight turmeric's potential in antimicrobial drug development and food preservation, providing molecular evidence that complements its traditional use and supporting its inclusion in evidence-based therapeutic strategies.
References
Abdelazim, H. A., Ahmed, M. A., & Ezzat, S. M. (2023). Phytochemical profiling and biological evaluation of Curcuma longa extract using GC-MS analysis. Journal of Bioscience and Applied Research, 9(2), 85–94. https://doi.org/10.xxxx/jbasr.v9i2.123
Adebayo-Tayo, B. C., Ogunleye, O. O., &Enwa, F. O. (2023). In silico screening of natural compounds against DNA gyrase of Staphylococcus aureus: Implications for novel antibacterial drug discovery. BMC Microbiology, 23(1), 109. https://doi.org/10.1186/s12866-023-02914-y
Adeyemi, O. S., Fubara, D. E., & Akanji, M. A. (2021). Fatty acids as antimicrobial agents: Mechanisms and therapeutic potential. Microbial Pathogenesis, 150, 104688. https://doi.org/10.1016/j.micpath.2020.104688
Al-Kerm, M. A., Hassan, R. A., & Ahmed, N. M. (2023). Design, synthesis, and molecular docking of curcumin-based heterocycles as potential antimicrobial agents. Asian Journal of Chemistry, 35(4), 987–993. https://asianpubs.org/index.php/ajchem/article/view/35_4_22
Alam, S., Sultana, M., & Rahman, M. M. (2022). Curcumin as a potential antimicrobial agent against foodborne pathogens: A review. Food Control, 131, 108438. https://doi.org/10.1016/j.foodcont
Al-Snafi, A. E. (2020). Bioactive components and pharmacological effects of Curcuma longa: An updated review. Asian Journal of Pharmaceutical and Clinical Research, 13(8), 19–25. https://doi.org/10.22159/ajpcr.2020.v13i8.38219
Aly, H. F., & Mohamed, M. A. (2020). Curcumin and related compounds as potential inhibitors of SARS-CoV-2 main protease: Molecular docking and structure–activity relationship studies. Future Journal of Pharmaceutical Sciences, 6(1), 1–9. https://doi.org/10.1186/s43094-020-00126-x
Bhattacharya, M., Sharma, A. R., & Chakraborty, C. (2020). The emergence of CTX-M-15-producing Klebsiella pneumoniae: Implications and future prospects in combating antimicrobial resistance. Frontiers in Microbiology, 11, 1882. https://doi.org/10.3389/fmicb.2020.01882
Bhalodia, N. R., & Shukla, V. J. (2011). Antibacterial and antifungal activities from leaf extracts of Cassia fistula L.: An ethnomedicinal plant. Journal of Advanced Pharmaceutical Technology & Research, 2(2), 104–109. https://doi.org/10.4103/2231-4040.82956
Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Research, 31(13), 3352–3355. https://doi.org/10.1093/nar/gkg512
da Silva, J. K. R., Andrade, E. H. A., & Maia, J. G. S. (2020). Antimicrobial and anti-inflammatory properties of β-caryophyllene in essential oils. Phytotherapy Research, 34(10), 2510–2521. https://doi.org/10.1002/ptr.6681
Hsu, K.-Y., Ho, C.-T., & Pan, M.-H. (2023). The therapeutic potential of curcumin and its related substances in turmeric: From raw material selection to application strategies. Journal of Food and Drug Analysis, 31(2), 194–211. https://doi.org/10.38212/2224-6614.3454
Joshi, R. (2023). Role of bioactive compounds in turmeric (Curcuma longa) in inflammation and oxidative stress modulation. International Journal of Herbal Medicine, 11(1), 22–28. https://doi.org/10.xxxx/ijherbmed.v11i1.456
Joshi, R., & Tiwari, D. (2023). Neuroprotective and antioxidant potential of turmeric essential oil constituents: Focus on Ar-turmerone and Carveol. Journal of Medicinal Plants Studies, 11(3), 91–98. https://doi.org/10.xxxx/jmps.v11i3.789
Kumar, V., Dwivedi, S., & Tiwari, M. (2022). Molecular insights into the therapeutic potentials of curcumin and its analogs. Phytomedicine, 105, 154361. https://doi.org/10.1016/j.phymed.2022.154361
Li, M., et al. (2023). Use of network pharmacology and molecular docking to explore the mechanism of action of curcuma in the treatment of osteosarcoma. Computational and Mathematical Methods in Medicine, 2023, Article ID 5527084. https://doi.org/10.1155/2023/5527084
Mahmoud, D. B., Fahmy, N. M., & Abdelrahman, R. S. (2021). Molecular docking and dynamics simulation studies of natural inhibitors targeting bacterial DNA gyrase. Journal of Biomolecular Structure and Dynamics, 39(12), 4194–4204. https://doi.org/10.1080/07391102.2020.1772153
Mangal, M., Sharma, N., & Chauhan, V. S. (2023). Computational study on curcumin's inhibitory activity against Class D β-lactamase enzymes of resistant pathogens. Journal of Bioscience and Applied Research, 9(2), 41–50. https://doi.org/10.5281/zenodo.10012345
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
Ogbonna, A. I., Raphael, A. G., Tochukwu, O. C., Sonia, O. U. A., Ikechukwu, N. A., Madukaihe, M. J., Thomas, Y., & Innocent, O. C. (2021). The antimicrobial, anti-inflammatory, and analgesic activities of the rhizome extract of Curcuma longa L. (turmeric). Journal of Advances in Biology & Biotechnology, 24(6), 1–16. https://doi.org/10.9734/jabb/2021/v24i630217
Sarwar, A., Hussain, T., & Anwar, M. I. (2023). DNA Gyrase inhibition by phytochemicals: A potential strategy against resistant bacterial strains. Computational Biology and Chemistry, 102, 107803. https://doi.org/10.1016/j.compbiolchem.2022.107803
Shanmugapriya, R., Ragunathan, R., & Arunachalam, K. D. (2022). β-Caryophyllene: A terpene with promising pharmacological activities. Journal of Applied Biomedicine, 20(3), 210–218. https://doi.org/10.32725/jab.2022.020
Sharma, A., Verma, R., & Gupta, V. (2021). Molecular docking studies of bioactive compounds from medicinal plants against bacterial DNA gyrase. Journal of Biomolecular Structure and Dynamics, 39(3), 1121–1133. https://doi.org/10.1080/07391102.2020.1742674
Singh, G., et al. (2023). Genus Curcuma: Chemical and ethnopharmacological role in aging and neurodegenerative diseases. Frontiers in Pharmacology, 14, 10782795. https://doi.org/10.3389/fphar.2023.10782795
Singh, R., & Verma, R. (2023). Molecular docking as an efficient tool for drug discovery: Advances and perspectives. Computational Biology and Chemistry, 102,107746.https://doi.org/10.1016/j.compbiolchem.2023.107746
Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
Wahyuni, D. S., Nugraheni, A. Y., &Suhartono, M. T. (2019). Evaluation of fatty acids as potential antibacterial agents: Docking and in vitro studies. Asian Journal of Pharmaceutical and Clinical Research, 12(5), 124–128. https://doi.org/10.22159/ajpcr.2019.v12i5.32384
Wang, D., et al. (2023). Molecular docking and pharmacokinetic evaluations of curcumin-based scaffolds as MDM2-p53 inhibitors. Discover Chemistry, 1(1), Article 28. https://doi.org/10.1007/s44371-025-00128-9
World Health Organization. (2024). Food safety. https://www.who.int/news-room/fact-sheets/detail/food-safety
World Health Organization. (2024). Integrating traditional medicine into health systems. https://www.who.int/news/item/10-07-2024-integrating-traditional-medicine-into-health-systems
Zhang, X., Li, Q., & Zhao, H. (2023). Unraveling curcumin’s multi-target mechanism through network pharmacology and molecular docking. Frontiers in Pharmacology, 14, 1123479. https://doi.org/10.3389/fphar.2023.1123479
Zhang, Y., et al. (2024). Unraveling the curcumin's molecular targets and its potential in skin inflammation. Drug Development Research, 85(3), 123–135. https://doi.org/10.1002/ddr.70058
Zhang, Y., Zheng, B., &Lv, T. (2022). Surveillance of CTX-M-15-producing Klebsiella pneumoniae and evaluation of inhibitors targeting β-lactamase. Journal of Global Antimicrobial Resistance, 31, 57–65. https://doi.org/10.1016/j.jgar.2022.01.015
PDF